Arabinose (L-Arabinose)

01/01/2015 - "After the rat model for metabolic syndrome was successfully established, L-arabinose was administrated by oral gavage for 6 weeks. "
01/01/2015 - "However, few reports have described the effect of L-arabinose in metabolic syndrome, a combination of medical disorders that increase the risk of diabetes and cardiovascular disease. "
01/01/2015 - "Protective effects of L-arabinose in high-carbohydrate, high-fat diet-induced metabolic syndrome in rats."
12/13/2019 - "L-Arabinose Elicits Gut-Derived Hydrogen Production and Ameliorates Metabolic Syndrome in C57BL/6J Mice on High-Fat-Diet."
01/01/2015 - "This study was conducted to explore the effects of L-arabinose in rats with metabolic syndrome induced by a high-carbohydrate, high-fat (HCHF) diet. "

10/01/1969 - "[Spinal administration of cytosine arabinose in a case of refractory meningocerebral leukemia]."
01/01/2019 - "Arabinose nucleoside derivatives such as fludarabine are effective in the treatment of patients with acute and chronic leukemias and non-Hodgkin's lymphomas. "
01/01/1987 - "The same compound--5-aminoisothiazolopyrimidine 1 in reaction with glucose, arabinose and ribose bromoderivatives was converted into N-glycosiloaminoisothiazolopyrimidies type 3. Some of the newly synthetized compounds appeared effective against L-1210 leukemia and Sa-180 sarcoma."
12/01/1996 - "Aracytidine (cytarabine, 1-beta-D-arabinofuranosylcytosine) is a synthetic analog of cytidine in which ribose is substituted by arabinose; it is used as a drug for the treatment of leukemia. "

11/22/2023 - "In summary, the results of the study have provided evidence supporting the beneficial effects of arabinose in mitigating the progression of colitis. "
12/04/2019 - "In this study, we aim to investigate whether l-arabinose could inhibit colitis by modulating gut microbiota. "
11/22/2023 - "Consequently, arabinose may hold promise as a therapeutic supplementation for the management of colitis."
01/01/2020 - "Correction to l-Arabinose Inhibits Colitis by Modulating Gut Microbiota in Mice."
12/04/2019 - "l-Arabinose Inhibits Colitis by Modulating Gut Microbiota in Mice."

01/01/2023 - "Antiobesity effect of L-arabinose via ameliorating insulin resistance and modulating gut microbiota in obese mice."
01/01/2023 - "Based on these results, L-arabinose could be a promising candidate for combating obesity and obesity-related diseases by regulating insulin resistance and gut microbiota."
01/01/2023 - "The aim of this study was to investigate L-arabinose, a unique functional sugar that improves insulin resistance and intestinal environment while promoting probiotic proliferation, for its potential in preventing obesity induced by a high-fat and high-sugar (HFHS) diet in mice. "
03/25/2023 - "These results suggest a potential for l-arabinose and specific rare disaccharides to improve metabolic health; however, additional in vivo research with longer sugar exposures should confirm their beneficial impact on insulin sensitivity in humans."
01/01/2015 - "This work suggests that L-arabinose could lower body weight, Lee's index, and visceral index and improve dyslipidemia, insulin resistance, inflammation, and viscera function, which indicate that it might be a promising candidate for therapies combating metabolic syndrome."

01/01/2023 - "Based on these results, L-arabinose could be a promising candidate for combating obesity and obesity-related diseases by regulating insulin resistance and gut microbiota."
01/01/2023 - "The aim of this study was to investigate L-arabinose, a unique functional sugar that improves insulin resistance and intestinal environment while promoting probiotic proliferation, for its potential in preventing obesity induced by a high-fat and high-sugar (HFHS) diet in mice. "
01/01/2015 - "L-Arabinose is a non-caloric sugar, which could affect glucose and lipid metabolism and suppress obesity. "
01/01/2022 - "Specifically, l-arabinose, a monosaccharide that is poorly absorbed in the gut and inhibits intestinal sucrase, suppresses diet-induced obesity in mice in the presence of sucrose. "
01/01/2023 - "Treatment with L-arabinose resulted in a reduction of various obesity symptoms, such as prevented weight gain, increased liver-to-body ratio, decreased insulin, homeostasis model assessment for insulin resistance (HOMA-IR) index, and lipopolysaccharide (LPS) levels, as well as improved insulin resistance, reduced fat volume, inhibited hepatic steatosis, and repaired the pancreas. "